This tender seeks proposals for the placement of an automated Polymerase Chain Reaction (PCR) system, including reagents, quality control materials, and maintenance services for five years. The system will enhance diagnostic capabilities in the Tshwane Academic Division Haematology Laboratory.
The National Health Laboratory Service (NHLS) is inviting bids for the procurement of an automated Polymerase Chain Reaction (PCR) system to be installed at the Tshwane Academic Division Haematology Laboratory. This system is essential for conducting various diagnostic genetic tests, including the detection of Factor II/prothrombin, Factor V Leiden, and BCR-ABL1 quantification. The successful bidder will provide not only the PCR system but also all necessary reagents, quality control materials, and consumables required for operation over a five-year period. Additionally, comprehensive service and maintenance support will be expected to ensure optimal performance and reliability of the system.
The scope of work includes the installation of a fully automated PCR system capable of nucleic acid extraction, PCR amplification, and detection. Bidders must demonstrate compliance with technical specifications, including real-time PCR capabilities, modular design, and robust software for results analysis. The system should support WHO International Standards for calibrators and provide extensive training for laboratory staff. This investment will significantly improve the laboratory's diagnostic efficiency and accuracy, ultimately benefiting patient care in the region.
This tender is suitable for businesses specializing in medical equipment supply, particularly those with experience in laboratory diagnostics and automated systems. Companies that provide comprehensive service and maintenance support for medical devices are also encouraged to apply.